References

Guidelines

• Incidentaloma

  • European: Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016 Aug;175(2):G1-G34. doi: 10.1530/EJE-16-0467. PMID: 27390021.

  • Candian (endorsed by the American Urological Association): Rowe NE, Kumar RM, Schieda N, et al. Canadian Urological Association guideline: Diagnosis, management, and followup of the incidentally discovered adrenal mass. Can Urol Assoc J. 2023;17(2):12-24. doi:10.5489/cuaj.8248

  • Korean: Lee JM, Kim MK, Ko SH, et al. Clinical Guidelines for the Management of Adrenal Incidentaloma. Endocrinol Metab (Seoul). 2017;32(2):200-218. doi:10.3803/EnM.2017.32.2.200

  • American (endocrine surgeons): Yip L, Duh QY, Wachtel H, et al. American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surgery. 2022;157(10):870-877. doi:10.1001/jamasurg.2022.3544

  • American (American College of Radiology white paper): Mayo-Smith WW, Song JH, Boland GL, et al. Management of incidental adrenal masses: a white paper of the acr incidental findings committee. Journal of the American College of Radiology. 2017;14(8):1038-1044.

• Conn’s syndrome: 

  • John W. Funder, Robert M. Carey, Franco Mantero, M. Hassan Murad, Martin Reincke, Hirotaka Shibata, Michael Stowasser, William F. Young, Jr, The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 101, Issue 5, 1 May 2016, Pages 1889–1916, https://doi.org/10.1210/jc.2015-4061 (from NCCN)

• Cushing’s syndrome: 

  • Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31. doi: 10.1210/jc.2015-1818. Epub 2015 Jul 29. PMID: 26222757; PMCID: PMC4525003.(from NCCN)

• Pheochromocytoma: 

  • Jacques W. M. Lenders, Quan-Yang Duh, Graeme Eisenhofer, Anne-Paule Gimenez-Roqueplo, Stefan K. G. Grebe, Mohammad Hassan Murad, Mitsuhide Naruse, Karel Pacak, William F. Young, Jr, Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 99, Issue 6, 1 June 2014, Pages 1915–1942, https://doi.org/10.1210/jc.2014-1498 (from NCCN)

  • European Network for the Study of Adrenal Tumors http://www.ensat.org/page-1652177

• Adrenocortical carcinoma

  • European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma Gaujoux S, Mihai R; joint working group of ESES and ENSAT. Br J Surg. 2017 Mar;104(4):358-376. - https://bjssjournals.onlinelibrary.wiley.com/doi/full/10.1002/bjs.10414

• Imaging

  • American College of Radiology Appropriateness Criteria: Adrenal Mass Evaluation https://acsearch.acr.org/docs/69366/Narrative/?_ga=2.186016288.840016715.1634540127-2043902518.1634105739

  • Mayo-Smith WW, Song JH, Boland GL, et al. Management of incidental adrenal masses: a white paper of the acr incidental findings committee. Journal of the American College of Radiology. 2017;14(8):1038-1044. https://www.jacr.org/article/S1546-1440(17)30551-3/fulltext

NCCN Guidelines

Sections of the National Comprehensive Cancer Network (NCCN) Neuroendocrine and Adrenal Tumor Guidelines (v2.2021) considered for this site include:

• AGT 1-5

• PHEO 1-3

• NE C

• MS 3

• MS 26-30

• MS 30-34